- Tissue factor, tissue factor pathway inhibitor and cytoadhesive molecules in patients with an acute coronary syndrome2003 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- The role of tissue factor in thrombosis and hemostasis2007 | Publication without faculty affiliation
- Should We Replace the Terms Intrinsic and Extrinsic Coagulation Pathways With Tissue Factor Pathway?2017 | Faculty of Medicine in Hradec Králové
- Time-Course of Tissue Factor Plasma Level in Patients with Acute Coronary Syndrome2009 | First Faculty of Medicine
- Patients with acute coronary syndromes have low tissue factor activity and microparticle count, but normal concentration of tissue factor antigen in platelet free plasma - a pilot study2009 | Publication without faculty affiliation
- Plasma tissue factor in coronary artery disease. Further step to the understanding of the basic mechanisms of coronary artery thrombosis2008 | First Faculty of Medicine
- Tissue factor, tissue factor pathway inhibitor, and soluble P-selectin levels in patients with acute coronary syndromes. A preliminary report.2002 | Central Library of Charles University, Second Faculty of Medicine
- Increased platelet residual activity in patients treated with acetosalicylic acid is associated with increased tissue factor and decreased tissue factor pathway inhibitor plasma levels2011 | Faculty of Medicine in Hradec Králové
- Tissue factor in acute coronary syndromes2003 | Second Faculty of Medicine
- Tissue factor, its inhibitor, and the thrombogenicity of two new synthetic membranes2005 | Faculty of Medicine in Pilsen, Central Library of Charles University
- Tissue factor, its inhibitor, and the thrombogenicity of two new synthetic membranes2005 | Publication without faculty affiliation
- Tissue factor, its pathway inhibitor, and metabolic disturbances in long-term peritoneal dialysis2003 | Faculty of Medicine in Pilsen, Central Library of Charles University
- Time-Course of Tissue Factor Plasma Level in Patients with Acute Coronary Syndrome2009 | Faculty of Medicine in Hradec Králové
- Plasma tissue factor in coronary artery disease. Further step to the understanding of the basic mechanisms of coronary artery thrombosis +12008 | Faculty of Medicine in Hradec Králové
- Time-course of tissue factor plasma level in patients with acute coronary syndromePublication without faculty affiliation
- Determination of concentrations of tissue factor pathway inhibitor and their changes during estrogen replacement therapy2007 | First Faculty of Medicine
- A 24-h work shift in intensive care personnel: biological pathways between work stress and ill health2011 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Oral but not transdermal estrogen replacement therapy reduced level of tissue factor pathway inhibitor: Cross-over designed study2006 | First Faculty of Medicine
- Activation of circulating elements - key to pathophysiology of acute coronary syndrome2005 | Faculty of Medicine in Hradec Králové
- Re: Shi et al. Protease-activated receptor 2 suppresses lymphangiogenesis and subsequent lymph node metastasis in a murine pancreatic cancer model. J Pathol 2014; 234: 398-4092015 | Central Library of Charles University, Third Faculty of Medicine
- Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study2021 | First Faculty of Medicine
- Is it possible to identify 'culprit lesion' in acute coronary syndromes?2004 | First Faculty of Medicine
- Low molecular heparins2004 | First Faculty of Medicine
- New insights into the pathophysiology of acute coronary syndrome2003 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Intestinal adaptation following gut resection2017 | First Faculty of Medicine
- Prevalence of hypercoagulable disorders in inflammatory bowel disease2014 | Faculty of Medicine in Hradec Králové
- Lipoprotein Apheresis in the Treatment of Dyslipidemia - the Czech Republic Experience2017 | Faculty of Medicine in Hradec Králové
- Successful prophylactic treatment of FEIBA in the prevention of bleeding in patients with severe haemophilia A and high titre of FVIII inhibitor2017 | Second Faculty of Medicine
- Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study2023 | First Faculty of Medicine